 |
| |
Assessing the environmental risk of pharmaceuticals
Concerns regarding the fate and effect of pharmaceuticals in the environment have increased following the detection of pharmaceuticals in sewage treatment plant effluents, surface waters, seawater, groundwater and even drinking water. More... |
| |
Working towards greener manufacturing
PTE spoke with Dr. Peter Dunn, Global Green Chemistry Lead at Pfizer, about the pharmaceutical industry's commitment to green manufacturing, some of the key changes that yield significant energy efficiencies and the strategy behind the company's green chemistry programme. More... |
| |
EU debt crisis adds uncertainty for contract services
Although the immediate nature of the EU debt crisis is financial and monetary, efforts to remedy it will ultimately strike the bio/pharma industry via reduced expenditures by governments. More... |
| |
H1N1 pandemic "vastly overrated" by WHO
The handling of the H1N1 pandemic by the World Health Organization (WHO), EU agencies and national governments led to a “waste of large sums of public money, and unjustified scares and fears about the health risks faced by the European public”, according to a report released by the Council of Europe. More... |
| |
When will personalized medicine deliver on its promise?
A recent survey has attempted to identify why the deployment of personalized medicine into mainstream medicine is occurring so slowly. More... |
| |
Pfizer initiates recall of three I.V. Drugs
Pfizer is voluntarily recalling metronidazole, ciprofloxacin and ondansetron intravenous (i.v.) products because of the presence of floating matter and non-sterility discovered by an Indian manufacturer. More... |
| |
Take part in PTE's short reader survey
What are we getting right and what can we improve upon? Give your opinion of Pharmaceutical Technology Europe by taking part in a short survey and be in with the chance of winning an iPod Touch! More... |
| |
|
| Podcast |
| Vetter |
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago.
Read more...
|
|
| Product Profiles |
| Agilent |
One for all with Agilent Multi-Vendor Services. Now you can get comprehensive repair, maintenance and compliance support for all major LC, GC and MS models in your lab regardless of manufacturer.
Read more...
|
|
| Gen-Probe |
We would like to invite all visitors to the Biotech Outsourcing Strategies (BOS) cmc conference, 17th June 2010 at Sohuset Conference Centre in Horsholm, Denmark to visit us on Stand C for a Scottish Malt Whisky tasting and chat to us about our Chemistry, Microbiology and Bioanalytical Services.
Read more...
|
|
| Shimadzu |
Shimadzu introduces the next generation LC-20AP Preparative LC pump, suitable for analytical, semi-prep and prep LC applications without changing pump heads.
Read more...
|
|
| Veltek |
Veltek’s new sterile clean room wipes
Veltek debuts new sterile clean room wipes, including the industry’s first sodium hypochlorite and hydrogen peroxide clean room wipes.
Read more...
|
|
 |
|
|
|
|
| Which anti counterfeiting solution is your company currently using? |
| ■ |
|
RFID 10% |
| ■ |
|
Barcoding 26% |
| ■ |
|
On-dose technologies 7% |
| ■ |
|
Tamper-evident packaging 19% |
| ■ |
|
Other 12% |
| ■ |
|
None 26% |
This week we would like to know...
Should the FDA have mandatory recall authority and the power to halt drug production?
|
|
Contact Us
Click here to contact editorial.
Click here to contact sales. |
|
